Literature DB >> 12587187

Thyroid hormone, neural tissue and mood modulation.

M Bauer1, P C Whybrow.   

Abstract

The successful treatment of affective disorders with thyroid hormone exemplifies the suggested inter-relationship between endocrine and neuronal systems in these disorders. Thyroid hormones have a profound influence on behaviour and appear to be capable of modulating the phenotypic expression of major affective illness. Specifically, there is good evidence that triiodothyronine (T3) may accelerate the antidepressant response to tricylic antidepressants, and some studies suggest that T3 may augment the therapeutic response to antidepressants in refractory depressed patients. Open studies have also indicated that adjunctive supraphysiological doses of thyroxine (T4) can ameliorate depressive symptomatology and help stabilize the long-term course of illness in bipolar and unipolar patients, especially women refractory to standard medications. Despite acceptance of the essential role of thyroid hormone on brain maturation and differentiation, and the clinical and therapeutic observations in association with mood disorders, the molecular action that may underlie the mood-modulating properties of thyroid hormone in the adult brain has only recently become the focus of research. The identification of nuclear T3 receptors, the region-specific expression of deiodinase isoenzymes and the molecular analyses of thyroid-responsive genes in the adult brain have provided the biological bases for a better understanding of thyroid hormone action in mature neurons. Also the influence of thyroid hormones on the putative neurotransmitter systems that regulate mood and behaviour, serotonin and norepinephrine, may be helpful in explaining their mood-modulating effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12587187     DOI: 10.3109/15622970109027495

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  13 in total

1.  Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Jae Kim; Scott M Rawls; Dianne Langford
Journal:  J Neurochem       Date:  2012-03-13       Impact factor: 5.372

2.  Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey.

Authors:  May A Beydoun; Hind A Beydoun; Monal R Shroff; Melissa H Kitner-Triolo; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2011-07-16       Impact factor: 4.673

3.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

4.  Neural correlates of free T3 alteration after catecholamine depletion in subjects with remitted major depressive disorder and in controls.

Authors:  Philipp Homan; Wayne C Drevets; Gregor Hasler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-18       Impact factor: 4.530

5.  Levothyroxine replacement therapy with vitamin E supplementation prevents oxidative stress and cognitive deficit in experimental hypothyroidism.

Authors:  Tianrong Pan; Mingkui Zhong; Xing Zhong; Yanqing Zhang; Defa Zhu
Journal:  Endocrine       Date:  2012-09-23       Impact factor: 3.633

Review 6.  Pain and thyroid hormones.

Authors:  Anna Maria Aloisi; Stella Vodo; Michelangelo Buonocore
Journal:  Neurol Sci       Date:  2013-04-23       Impact factor: 3.307

7.  Thyroid hormones are associated with cognitive function: moderation by sex, race, and depressive symptoms.

Authors:  M A Beydoun; H A Beydoun; M H Kitner-Triolo; J S Kaufman; M K Evans; A B Zonderman
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

8.  Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.

Authors:  Tom Bschor; Christopher Baethge; Mazda Adli; Ute Lewitzka; Uta Eichmann; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

9.  Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis.

Authors:  M Piga; A Serra; L Deiana; G L Loi; L Satta; M Di Liberto; S Mariotti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

10.  Thyroid hormone and the neuroglia: both source and target.

Authors:  Petra Mohácsik; Anikó Zeöld; Antonio C Bianco; Balázs Gereben
Journal:  J Thyroid Res       Date:  2011-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.